The health of migrants and refugees, which has long been a cause for concern, has come under greatly increased pressure in the last decade. Against a background where the world has witnessed the largest numbers of migrants in history, the advent of the COVID-19 pandemic has stretched the capacities of countries and of aid, health and relief organizations, from global to local levels, to meet the human rights and pressing needs of migrants and refugees for access to health care and to public health measures needed to protect them from the pandemic. The overview in this article of the situation in examples of middle-income countries that have hosted mass migration in recent years has drawn on information from summaries presented in an M8 Alliance Expert Meeting, from peer-reviewed literature and from reports from international agencies concerned with the status and health of migrants and refugees. The multi-factor approach developed here draws on perspectives from structural factors (including rights, governance, policies and practices), health determinants (including economic, environmental, social and political, as well as migration itself as a determinant) and the human security framework (defined as “freedom from want and fear and freedom to live in dignity” and incorporating the interactive dimensions of health, food, environmental, economic, personal, community and political security). These integrate as a multi-component ‘ecological perspective’ to examine the legal status, health rights and access to health care and other services of migrants and refugees, to mark gap areas and to consider the implications for improving health security both for them and for the communities in countries in which they reside or through which they transit.
This study, as a part of the 'Medical Education without Discrimination (MED) Project," focuses on investigating attitudes toward sexual minorities and demographics among Turkish medical students. In the needs assessment phase of MED Project, a survey covering demographics, sexual orientation, attitudes toward sexual minorities, and Index of Attitudes Toward Homosexuals by Hudson & Ricketts (6-point Likert) was conducted among 523 medical students of one public and two nonprofit private medical schools in Istanbul. Of the students, 4.2% declared themselves as non-heterosexual. The findings highlight that medical students are on the verge of homophobia (44th percentile). Homophobia was significantly higher among public university students, males, younger individuals, those who originated from underdeveloped settlements, those who grew up with mothers who did not graduate from university, those who considered themselves less happy, and those without LGBTI+ acquaintances. Of the respondents, 14.1% do not perceive LGBTI+ people as equals within the community, and 75.7% assert that they would conceal their own LGBTI+ identity if they were part of this community. This study highlights that the need for targeted interventions in medical education in line with the global commitment to reduce inequalities and promote inclusive health care.
Objective: Türkiye is the leading country that has been applying the MPOWER criteria of the World Health Organization for years. However, the prevalence of smoking among nurses appears to be high, according to the literature. Therefore, we aimed to determine the prevalence, addiction levels, and dynamics of tobacco smoking among nurses in Türkiye. Method: In this descriptive cross-sectional study, a questionnaire (prepared in cooperation with the “World Health Organization”) and the Fagerström Test for Nicotine Dependence were administered to 529 nurses working at a tertiary-care university hospital in 2020. Logistic regression was performed to determine factors predicting smoking. Results: The prevalence of smoking among nurses was 32.7% (n = 173). The mean Fagerström test score indicated a "low dependence" level (score: 3 ± 2.6). Both results were higher for males. A relationship was found between trying smoking cigarette and hookah. Of the “current smokers” group, 102 (60.4%) stated that they wanted to quit smoking. Only 21 (27.6%) of the nurses who have tried to quit smoking thus far have received professional help. Conclusion: The prevalence of smoking among nurses working at a tertiary-care university hospital was relatively low compared to that among nurses in Türkiye. While females are normally expected to smoke less, the high prevalence of smoking among nurses (most of them female) raises the question of the professional basis of this situation. However, the low rate of receiving professional help reveals the lack of promotion and accessibility of smoking cessation outpatient clinics in the faculty environment. Finally, the perception that hookah is an alternative tobacco product leads to cigarette smoking. The good news was that nurses had a low dependency rate.
28 March 2022 in Primary Health Care Research & Development
Aim: To compare the competencies of primary care physicians (PCPs) with poor and good prescribing performance in frequently encountered indications. Background: Primary care centers are one of the mostly visited health facilities by the population for different health issues. Methods: In this cross-sectional study, we analyzed 6 125 487 prescriptions generated by 1431 PCPs which were selected by systematic sampling in 2016 in Istanbul. We defined PCPs as poor prescriber (n = 227) or good prescriber (n = 210) in terms of their prescribing performance per WHO/INRUD criteria. We compared solo diagnosis prescriptions of these two groups in ‘percentage of prescriptions in compliance with clinical guidelines’ and also rational prescribing indicators. Findings: Poor prescribers and good prescribers significantly differed in each of the prescribing indicators for their all solo diagnosis prescriptions. Hypertension had the highest difference of the average cost per encounter (Δ = 284.2%) between poor prescribers (US11.45 ± 45.0), whereas headache had the highest difference between the groups in the percentage encounters with an antibiotic (14.9% vs. 1.5%). Detailed analysis of the prescribing performances showed significantly higher values of each WHO/INRUD indicators for all examined diagnoses. We found significantly higher percentages of guideline-compliant drugs in good prescribers compared to that in poor prescribers in hypertension (40.8% vs 34.8%), tonsillopharyngitis (57.9% vs 50.7%), and acute sinusitis (46.4% vs 43.6%). Conclusion: This study shows that the prescribing performances of PCPs are not rational enough in terms of drug selection and prescription content. Furthermore, even the physicians who have good prescribing practice appear as not satisfactorily rational in compliance with current pharmacotherapy competencies.
To evaluate the cost-effectiveness of introducing Human Papillomavirus (HPV) vaccination into Türkiye’s National Immunization Program. The analysis employed the WHO-endorsed PRIME model in Microsoft Excel. Two vaccination strategies were simulated for 12-year-old girls: Scenario 1 (bivalent or quadrivalent vaccine) and Scenario 2 (nonavalent vaccine). Each scenario was assessed from both the Social Security Institution (SGK) and societal perspectives. Incremental cost-effectiveness ratios (ICERs) were calculated per disability-adjusted life year (DALY) averted, with sensitivity analyses conducted to test model robustness. Scenario 1 yielded an ICER of USD 2,231 per DALY averted, while Scenario 2 produced an ICER of USD 2,342. The incremental ICER of Scenario 2 versus Scenario 1 was USD 2,592. According to WHO cost-effectiveness thresholds, both scenarios were classified as “very cost-effective.” Sensitivity analyses identified the discount rate as the most influential factor, followed by vaccine efficacy, HPV subtype distribution, and vaccine price. The annual program cost to SGK was estimated at USD 15.7 million for Scenario 1 and USD 23.6 million for Scenario 2. Vaccination remained highly cost-effective at prices up to USD 54 (Scenario 1) and USD 78 (Scenario 2), but not cost-effective above USD 167 and USD 242, respectively. HPV vaccination is highly cost-effective in Türkiye, with both strategies offering substantial health gains and favorable ICERs well below national GDP per capita. Adoption of a national HPV vaccination program would likely reduce cervical cancer morbidity and mortality while representing an efficient use of healthcare resources.